GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific...
GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
About this item
Full title
Author / Creator
Credle, J J , George, J L , Wills, J , Duka, V , Shah, K , Lee, Y-C , Rodriguez, O , Simkins, T , Winter, M , Moechars, D , Steckler, T , Goudreau, J , Finkelstein, D I and Sidhu, A
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Aberrant posttranslational modifications (PTMs) of proteins, namely phosphorylation, induce abnormalities in the biological properties of recipient proteins, underlying neurological diseases including Parkinson’s disease (PD). Genome-wide studies link genes encoding
α
-synuclein (
α
-Syn) and Tau as two of the most important in the gene...
Alternative Titles
Full title
GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4392080
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4392080
Other Identifiers
ISSN
1350-9047
E-ISSN
1476-5403
DOI
10.1038/cdd.2014.179
